Has Amy Schorn received payments from drug or device companies?

Yes. Drug and device makers reported $6,182 in general payments to Amy Schorn across 211 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amy Schorn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amy Schorn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amy Schorn

Family · Scottsdale, AZNPI 1457583189

Payments from drug & device makers

$6,182in general payments, 2019–2025

Across 211 payments — averaging $29.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Array Biopharma Inc$869
AstraZeneca$579
E.r. Squibb & Sons, L.L.C.$327
Pfizer$327
AbbVie$289
Bristol Myers Squibb$258
plus $4K from 45 others

What the payments were for

Consulting fees$4006%
Speaking & faculty fees$72012%
Food & beverage$4,89579%
Education$1673%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Array Biopharma Inc	11	$869
AstraZeneca	6	$579
E.r. Squibb & Sons, L.L.C.	12	$327
Pfizer	18	$327
AbbVie	11	$289
Bristol Myers Squibb	8	$258
Amgen	11	$224
Seagen Inc.	5	$221
Johnson & Johnson	6	$209
Inari Medical, Inc.	1	$199
Novartis	9	$180
GSK	9	$172
Merck	8	$170
Daiichi Sankyo Inc.	7	$152
Sanofi	7	$143
Pharmacyclics LLC, An Abbvie Company	6	$127
Genentech USA, Inc.	5	$125
Pharmaessentia USA Corporation	1	$124
Takeda Pharmaceuticals U.S.A., Inc.	4	$123
Eisai Inc.	6	$117
Rigel Pharmaceuticals, Inc.	5	$78
Exelixis Inc.	3	$74
Stemline Therapeutics Inc.	3	$71
EMD Serono, Inc.	4	$70
Tersera Therapeutics LLC	2	$65
Sumitomo Pharma America, Inc.	1	$60
Bayer	3	$60
Incyte Corporation	3	$59
Blueprint Medicines Corporation	3	$58
Deciphera Pharmaceuticals Inc.	3	$56
Boehringer Ingelheim	2	$52
Gilead	2	$49
Ipsen Biopharmaceuticals, Inc	3	$47
Puma Biotechnology, Inc.	2	$41
G1 Therapeutics, Inc.	2	$41
Morphosys, US Inc.	2	$37
Astellas Pharma US Inc	2	$37
Sobi, Inc	2	$28
Ferring Pharmaceuticals Inc.	1	$27
Legend Biotech USA Inc.	1	$26
Genmab U.S., Inc.	1	$25
EUSA Pharma (US) LLC	1	$25
Jazz Pharmaceuticals Inc.	1	$22
Progenics Pharmaceuticals, Inc.	1	$21
Azurity Pharmaceuticals, Inc.	1	$20
Novocure Inc.	1	$19
Springworks Therapeutics, Inc.	1	$19
Secura Bio, Inc.	1	$18
Acrotech Biopharma Inc.	1	$14
Mirati Therapeutics, Inc.	1	$14
Helsinn Therapeutics (U.S.), Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,182 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	14	$18,449
Oxycodone Hcl	15	$347

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$327	$18,44914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.

Other family in Scottsdale

Kaitlyn LouchheimScottsdale$208K
Jennifer PrinceScottsdale$76K
Camilla BinksScottsdale$62K
Jessica TapiaScottsdale$36K
Dawn MougelScottsdale$34K
Keegan RussellScottsdale$28K
Jamie HowardScottsdale$14K
Anna CramerScottsdale$14K
Sharon MagalonaMesa$449K
Angela GoldenMunds Park$378K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →